FDA Grants Approval for Dimethyl Sulfoxide ANDA220173
The FDA has granted approval for ANDA220173, a generic application for Dimethyl Sulfoxide submitted by STIRA.
Therapeutic Area
Therapeutic area intelligence for Solvent with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.